8-K

Company

Skye Bioscience, Inc.

Filed

December 20, 2021

Period of Report

December 14, 2021

Accession Number

0001516551-21-000031

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →